ClinConnect ClinConnect Logo
Search / Trial NCT04408885

Rehabilitation Treatment of Anterior Cruciate Ligament Rupture

Launched by AARHUS UNIVERSITY HOSPITAL · May 26, 2020

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring how effective a non-surgical rehabilitation program is for patients with an Anterior Cruciate Ligament (ACL) injury. The goal is to see if this treatment helps improve patients' knee function and overall quality of life, and to find out how many patients eventually need surgery instead. The study is currently looking for participants aged between 18 and 62 years who have chosen a rehabilitation approach for their ACL injury.

If you decide to participate, you will be asked to complete surveys about your knee function and daily activities. The trial is open to all genders, but you won’t be eligible if you have other knee ligament issues, rheumatoid arthritis, or a specific type of arthritis called Morbus Bechterews Disease. This is an important opportunity to help researchers understand better ways to treat ACL injuries without surgery, potentially benefiting many others in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Anterior cruciate ligament injury where rehabilitation regime is selected as treatment.
  • Exclusion Criteria:
  • Other knee ligament instability
  • Rheumatoid arthritis
  • Morbus Bechterews Disease

About Aarhus University Hospital

Aarhus University Hospital is a leading research institution in Denmark, dedicated to advancing medical science and improving patient care through innovative clinical trials. As a key sponsor of clinical research, the hospital integrates cutting-edge technology and multidisciplinary expertise to conduct studies that address critical health challenges. With a commitment to ethical standards and patient safety, Aarhus University Hospital collaborates with a diverse network of academic and industry partners, ensuring that its research initiatives contribute to the global body of medical knowledge and enhance treatment options for patients.

Locations

Aarhus N, , Denmark

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials